Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

The objective of this case-control study was to compare the efficacy and toxicity of lenalidomide plus dexamethasone (len/dex) versus thalidomide plus dexamethasone (thal/dex) as initial therapy for newly diagnosed myeloma. We retrospectively studied 411 newly diagnosed patients treated with len/dex...

Full description

Saved in:
Bibliographic Details
Main Authors: Gay, Francesca, Hayman, Suzanne R., Lacy, Martha Q., Buadi, Francis, Gertz, Morie A., Kumar, Shaji, Dispenzieri, Angela, Mikhael, Joseph R., Bergsagel, P. Leif, Dingli, David, Reeder, Craig B., Lust, John A., Russell, Stephen J., Roy, Vivek, Zeldenrust, Steven R., Witzig, Thomas E., Fonseca, Rafael, Kyle, Robert A., Greipp, Philip R., Stewart, A. Keith, Rajkumar, S. Vincent
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2010
Subjects:
Clinical Trials and Observations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2826759/
https://ncbi.nlm.nih.gov/pubmed/20008302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-08-239046
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items